Patents by Inventor Dorit Farfara

Dorit Farfara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9649507
    Abstract: Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade ?-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: May 16, 2017
    Assignee: RAMOT AT TEL AVIV UNIVERSITY LTD.
    Inventors: Uri Oron, Hana Tuby, Dan Frenkel, Dorit Farfara
  • Publication number: 20160325115
    Abstract: Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade ?-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.
    Type: Application
    Filed: July 20, 2016
    Publication date: November 10, 2016
    Inventors: Uri Oron, Hana Tuby, Dan Frenkel, Dorit Farfara
  • Patent number: 9403030
    Abstract: Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade ?-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.
    Type: Grant
    Filed: March 25, 2012
    Date of Patent: August 2, 2016
    Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Uri Oron, Hana Tuby, Dan Frenkel, Dorit Farfara
  • Patent number: 8901074
    Abstract: An insulin degrading enzyme (IDE) inhibitor for use in the treatment of a disease selected from the group consisting of an autoimmune disease of the central nervous system and a neurodegenerative disease is disclosed.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: December 2, 2014
    Assignee: Ramot at Tel-Aviv University
    Inventors: Dan Frenkel, Hilit Levy, Nofit Borenstein, Dorit Farfara, Dorit Trudler
  • Publication number: 20140039581
    Abstract: Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade ?-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe.
    Type: Application
    Filed: March 25, 2012
    Publication date: February 6, 2014
    Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Uri Oron, Hana Tuby, Dan Frenkel, Dorit Farfara
  • Publication number: 20130130976
    Abstract: An insulin degrading enzyme (IDE) inhibitor for use in the treatment of a disease selected from the group consisting of an autoimmune disease of the central nervous system and a neurodegenerative disease is disclosed.
    Type: Application
    Filed: August 4, 2011
    Publication date: May 23, 2013
    Inventors: Dan Frenkel, Hilit Levy, Nofit Borenstein, Dorit Farfara, Dorit Trudler